Focus: Jupiter Endovascular is a pre-revenue medical device company focused on endovascular intervention for pulmonary embolism, based in Menlo Park, CA. The company operates in a specialized niche within respiratory and cardiovascular disease treatment.
Profile data last refreshed 16h ago · AI intelligence enriched 2w ago
Stable — net -2 jobs in 30d
2 added, 4 removed. Backfill posture.
Jupiter Endovascular is a high-risk, high-optionality early-stage device play best suited for professionals comfortable with startup volatility and seeking hands-on roles in device commercialization.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Jupiter Endovascular
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Jupiter Endovascular's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles